Relationship between circulating leptin and peripheral fat distribution in obese subjects

International Journal of Obesity

Volumn 21, Issue 4, 1997, Pages 255-260

  Lonnqvist F ^a   Wennlund, A ^a   Arner, P ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Dyslipidemia; Gender; Glucose intolerance; Hyperinsulinemia; Insulin resistance; Obesity

Indexed keywords

CATECHOLAMINE DERIVATIVE; INSULIN; LEPTIN; LIPOPROTEIN; PLASMINOGEN ACTIVATOR INHIBITOR 1;

ADULT; ARTICLE; ATHEROGENESIS; BLOOD PRESSURE; BODY FAT; BODY MASS; CATECHOLAMINE BLOOD LEVEL; ENERGY EXPENDITURE; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; INSULIN SENSITIVITY; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REGRESSION ANALYSIS; RISK FACTOR; SATIETY;

EID: 0030966660     PISSN: 03070565     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.ijo.0800394     Document Type: Article

References (20)

1. Björntorp P. Metabolic implications of body fat distribution. Diabetes Care 1991; 14: 1132-1143.
2. Bouchard C, Pérusse L. Genetics of obesity. Annu Rev Nutr 1993; 13: 337-354.
3. Zhang Y et al. Positional cloning of the mouse obese gene and its human homologue. Nature 1994; 372: 425-432.
4. Tartaglia L. et al. Identification and expression cloning of a leptin receptor, OB-R. Cell 1995; 85: 1263-1271.
5. Lönnqvist F. The obese (ob) gene and its product leptina new route toward obesity treatment in man? Q J Med 1996; 89: 327-332.
6. Lönnqvist F, Arner P. Nordfors L. Schalling M. Overexpression of the obese (ob) gene in human obese subjects. Nature Med 1995; 1: 950-953.
7. Maffei M et al. Leptin levels in human and rodent: Measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nature Med 1995; 1: 1155-1161.
8. Considine RV et al. Serum immunoreactive-leptin concentrations in normal-weight and obese humans. New Engl J Med 1996; 334: 292-295.
9. Masuzaki H. et al. Human obese gene expression. Adipocyte-specific expression and regional differences in the adipose tissue. Diabetes 1995; 44: 855-858.
10. Young RP et al. The short insulin tolerance test: Feasibility study using venous sampling. Diabetic Med 1996; 13: 429-433.
11. Haffner SM et al. Leptin concentrations in diabetic and nondiabetic Mexican-Americans. Diabetes 1996; 45: 822-824.
12. Dagogo-Jack S. et al. Plasma leptin and insulin relationships in obese and nonobese humans. Diabetes 1996; 45: 695-698.
13. Vidal H. et al. The expression of ob gene is not acutely regulated by insulin and fasting in human abdominal subcutaneous adipose tissue J Clin Invest 1996; 98: 251-255.
14. Sinha MK et al. Nocturnal rise of leptin in lean, obese, and non-insulin-dependent diabetes mellitus subjects. J Clin Invest 1996; 97: 1344-1347.
15. Kolaczynski JW et al. Acute and chronic effect of insulin on leptin production in humans. Diabetes 1996; 45: 699-701.
16. Caro J. et al. Decreased cerebrospinal-fluid/serum leptin ratio in obesity: a possible mechanism for leptin resistance. Lancet 1996; 348: 159-161.
17. Schwartz MW et al. Cerebrospinal fluid leptin levels: Relationship to plasma levels and to adiposity in humans. Nature Medicine 1996; 2: 589-591.
18. Chehab FF, Lim ME, Ronghua Lu. Correction of the sterility defect in homozygous obese female mice by treatment with the human recombinant leptin. Nature Genetics 1996; 12: 318-320.
19. Ahima RS et al. Role of leptin in the neuroendocrine response to fasting. Nature 1996; 382: 250-252.
20. Gwo-Hwa L. et al. Abnormal splicing of the leptin receptor in diabetic mice. Nature 1996; 379: 632-635.